Enhanced neutrophil extracellular trap formation in COVID-19 is inhibited by the PKC inhibitor ruboxistaurin (2021)

First Author: Dowey R
Attributed to:  Phase 1 COVID-19 Immunity - National Core Study funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2021.08.24.21262336

Publication URI: http://dx.doi.org/10.1101/2021.08.24.21262336

Type: Preprint